1 Mestecky, J., Russell, M. W., Jackson, S. and Brown, T. A. The human IgA system: a reassessment. Clinical immunology and immunopathology. vol 40: 105-114; 1986.
2 Stockley, R. A., Mistry, M., Bradwell, A. R. and Burnett, D. A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax. vol 34: 777-782; 1979.
3 Newkirk, M. M., Klein, M. H., Katz, A., Fisher, M. M. and Underdown, B. J. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease. Journal of immunology (Baltimore, Md. : 1950). vol 130: 1176-1181; 1983.
4 Morton, H. C., van Egmond. M. and van de Winkle J. G. Structure and function of human IgA Fc receptors (FcαR). Critical Reviews in Immunology. vol 16: 423-440; 1996.
5 Stockley, R. A., Afford, S. C. and Burnett, D. Assessment of 7S and 11S immunoglobulin A in sputum. The American review of respiratory disease. vol 122: 959-964; 1980.
6 Puchelle, E., Jacqot, J. and Zahm, J. M. In vitro restructuring effect of human airway immunoglobulins A and lysozyme on airway secretions. European journal of respiratory diseases. Supplement. vol 153: 117-122; 1987.
7 Lebreton, C., Menard, S., Abed, J., Moura, I. C., Coppo, R., Dugave, C., Monteiro, R. C., Fricot, A., Traore, M. G., Griffin, M., Cellier, C., Malamut, G., Cerf-Bensussan, N. and Heyman, M. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology. vol 143: 698-707; 2012.
8 Abu-Ghazaleh, R. I., Fujisawa, T., Mestecky, J., Kyle, R. A. and Gleich, G. J. IgA-induced eosinophil degranulation. Journal of immunology (Baltimore, Md. : 1950). vol 142: 2393-2400; 1989.
9 Iikura, M., Yamaguchi, M., Fujisawa, T., Miyamasu, M., Takaishi, T., Morita, Y., Iwase, T., Moro, I., Yamamoto, K. and Hirai, K. Secretory IgA induces degranulation of IL-3-primed basophils. Journal of immunology (Baltimore, Md. : 1950). vol 161: 1510-1515; 1998.
10 Bartemes, K. R., Cooper, K. M., Drain, K. L. and Kita, H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. Journal of Allergy and Clinical Immunology. vol 116: 827-835; 2005.
11 Diven, S. C., Caflisch, C. R., Hammond, D. K., Weigel, P.H., Oka, J. A. and Goldblum, R. M. IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD89). Kidney International. vol 54: 837-847; 1998.
12 Natsuizaka, M., Chiba, H., Kuronuma, K., Otsuka, M., Kudo, K., Mori, M., Bando, M., Sugiyama, Y. and Takahashi H. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. American journal of respiratory and critical care medicine. vol 190: 773-779; 2014.
13 Idiopathic Pulmonary Fibrosis Clinical Reseach Network, Raghu. G., Anstrom, K. J., King, T. E. Jr., Lasky, J. A. and Martinez, F. J. Predonisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis. New England Journal of Medicine. vol 366: 1968-77; 2012.
14 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会(編): 特発性間質性肺炎 診断と治療の手引き, 第 3 版, 南江堂, 東京, 2016.
15 Lederer, D. J. and Martinez, F. J. Idiopathic Pulmonary Fibrosis. The New England Journal of Medicine. vol 378: 1811-1823; 2018.
16 Ten Klooster, L., van Moorsel, C. H., Kwakkel-van Erp, J. M., van Velzen-Blad, H. and Grutters, J. C. Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis. Clinical and Experimental Immunology. vol 181: 357-361; 2015.
17 Reynolds, H. Y., Fulmer, J. D., Kazmierowski, J. A., Roberts, W. C., Frank, M. M. and Crystal, R. G. Analysis of Cellular and Protein Content of Broncho-Alveolar Lavage Fluid from Patients with Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonaitis. The Journal of Clinical Investigation. Vol. 59: 165-175; 1977.
18 King, T. E., Pardo, A. and Selman, M. Idiopathic pulmonary fibrosis. The Lancet. vol 378: 1949-1961; 2011.
19 Tsukui, T., Ueha, S., Shichino, S., Inagaki, Y. and Matsushima, K. Intratracheal cell transfer demonstrates the profibrotic potential of resident fibroblasts in pulmonary fibrosis. The American Journal of Pathology. vol 185: 2939-2948; 2015.
20 Hackett, T. L. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Current Opinion in Allergy and Clinical Immunology. vol. 12: 53-9; 2012.
21 Ganesan, S. and Sajjan, U. S. Repair and Remodeling of airway epithelium after injury in Chronic Obstructive Pulmonary Disease. Current Respiratory Care Reports. vol 2: 2013.
22 Kim, E. S., Kim, M. S. and Moon. A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. International Journal of Oncology. vol 25: 1375-1382; 2004.
23 Liu, R. M. and Desai, L. P. Reciprocal regulation of TGF-beta and reactive oxygen species: A perverse cycle for fibrosis. Redox Biology. vol 6: 565-77; 2015.
24 Wynn, T. A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The journal of Clinical Investigation. vol 117: 534-529; 2007
25 Borsutzky, S., Cazac, B. B., Roes, J. and Guzmán, C. A. TGF-β Receptor Signaling Is Critical for Mucosal IgA Responses. The Journal of Immunology. vol 173: 3305-3309; 2004.
26 Sakai, N. and Tager, A. M. Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis. Biochimica et Biophysica Acta. vol 1832: 911-921; 2013.
27 Kobayashi, T., Liu, X., Kim, H. J., Kohyama, T., Wen, F. Q., Abe, S., Fang, Q., Zhu, Y. K., Spurzem, J. R., Bitterman, P. and Rennard, S. I. TGF-beta1 and serum both stimulate contraction but differentially affect apoptosis in 3D collagen gels. Respiratory Research. vol 6: 141; 2005.
28 Sakota, Y., Ozawa, Y., Yamashita, H., Tanaka, H. and Inagaki, N. Collagen Gel Contraction Assay Using Human Brochial Smooth Muscle Cells and Its Application for Evaluation of Inhibitory Effect of Formoterol. Biological and Pharmaceutical Bulletin. vol 37: 1014-1020; 2014.
29 Smith, R. S., Fedyk, E. R., Springer, T. A., Mukaida, N., Iglewski, B. H. and Phipps, R. P. IL-8 Production in Human Lung Fibroblasts and Epithelial Cells Activated by the Pseudomonas Autoinducer N-3-Oxododecanoyl Homoserine Lactone Is Transcriptionally Regulated by NF-kappa B and Activator Protein-2. The Journal of Immunology. vol 167: 366-374; 2001.
30 Azghani, A. O., Neal, K., Idell, S., Amaro, R., Baker, J. W., Omri, A. and Pendurthi, U. R. Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase. Microbiology. vol 160: 547-555; 2014.
31 Sheppard, D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proceedings of the American Thoracic Society. vol 3: 413-417; 2006.
32 Phan, S.H. Biology of Fibroblasts and Myofibroblasts. Proceedings of the American Thoracic Society. vol 5: 334-337; 2008
33 Hinz, B., Phan, S.H., Thannickal, V. J., Prunotto, M., Desmouliere, A., Verga, J., De Wever, O., Mareel, M. and Gabbiani, G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. The American Journal of Pathology. vol 180: 1340-1355; 2012.
34 Moore, M. W. and Herzog, E. L. Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis. Current Pathobiology Report. vol 1: 199-208; 2013.
35 Woof, J. M. and Kerr, M. A. The function of immunoglobulin A in immunity. The Journal of Pathology. vol 208: 270-282; 2006.
36 Ouyang, X., Ghani, A. and Mehal, W. Z. Inflammasome biology in fibrogenesis. Biochimica et Biophysica Acta. vol 1832: 979-988; 2013.
37 Libermann, T. A. and Baltimore, D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular Cell Biology. vol. 10: 2327-2334; 1990.
38 Braiser, A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovascular Research. vol 86: 211-218; 2010.
39 Kunsch, C. and Rosen, C. A. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Molecular Cell Biology. vol. 13: 6137-46; 1993.
40 Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y. and Okubo, T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. The Journal of Immunology. vol. 153: 2052-63; 1994.
41 Rovin, B. H., Dickerson, J. A., Tan, L. C. and Hebert, C. A. Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney International. vol 48: 1263-1271; 1995.
42 Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T. and Gerritsen, M. E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. The Journal of Biological Chemistry. vol. 272: 21096-21103; 1997.
43 Karin, M., Liu, Zu. and Zandi, E. AP-1 function and regulation. Current Opinion in Cell Biology. vol 2: 240-246; 1997
44 Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M. and Anderson, D. W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proceedings of the National Academy of Sciences of the United States of America. vol. 98: 13681–13686; 2001.
45 Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. Federation of European Biochemical Societies Letters. vol. 364: 229-233; 1995.
46 Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A. and Trzaskos, J. M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. The Journal of Biological Chemistry. vol. 273: 18623; 1998.
47 van de Graaf, E. A., Out, T. A., Kobesen, A. and Jansen, H. M. Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma. Lung. vol 169: 275-283; 1991.
48 Wiggins, J., Hill, S. L. and Stockley, R. A. The secretory IgA system of lung secretions in chronic obstructive bronchitis: comparison of sputum with secretions obtained during fiberoptic bronchoscopy. Thorax. vol 39: 517-523; 1984.
49 Burnett, D. Immunoglobulins in the lung. Thorax. vol 41: 337-344; 1986
50 Weltzin, R., Traina-Dorge, V., Soike, K., Zhang, J. Y., Mack, P., Soman, G., Drabik, G. and Monath, T. P. Internasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. The Journal of Infectious Diseases. Vol 174: 256-61; 1996
51 Yel, L. Selective IgA deficiency. The Journal of Clinical Immunology. vol 30: 10-16; 2010.
52 Arnaboldi, P. M., Behr, M. J. and Metzger, D. W. Mucosal B Cell Deficiency in IgA-/- Mice Abrogates the Development of Allergic Lung Inflammation. The Journal of Immunology. vol 175: 1276-1285; 2005.
53 Tumlin, J. A., Lohavichan, V. and Hennigar, R. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. vol 18: 1321-1329; 2003.
54 Matysiak-Budnik, T., Moura, I. C., Arcos-Fajardo, M., Lebreton, C., Menard, S., Candalh, C., Ben-Khalifa, K., Dugave, C., Tamouza, H., van Niel, G., Bouhnik, Y., Lamarque, D., Chaussade, S., Malamut, G., Cellier, C., Cerf-Bensussan, N., Monteiro, R. C. and Heyman, M. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. The Journal Experimental Medicine. vol 205: 143-154; 2008.
55 Oortwijn, B. D., van der Boog, P. J., Roos, A., van der Geest, R. N., de Fijter, J. W., Daha, M. R. and van Kooten, C. A pathogenic role for secretory IgA in IgA nephropathy. Kidney International. vol 69: 1131-1138; 2006.
56 Al-Muhsen, S., Johnson, J. R. and Hamid, Q. Remodeling in asthma. Journal of Allergy and Clinical Immunology. vol 128: 451-462; 2011
57 Decramer, M., Janssens, W. and Miravitlles, M. Chronic obstructive pulmonary disease. The Lancet. vol 379: 1341-51; 2012
58 Fielding, C. A., Jones, G. W., McLoughlin, R. M., McLeod, L., Hammond, V. J., Uceda, J., Williams, A. S., Lambie, M., Foster, T. L., Liao, C. T., Rice, C. M., Greenhill, C. J., Colmont, C. S., Hams, E., Coles, B., Kift-Morgan, A., Newton, Z., Craig, K. J., Williams, J. D., Williams, G. T., Davies, S. J., Humphreys, I. R., O'Donnell, V. B., Taylor, P. R., Jenkins, B. J., Topley, N. and Jones, S. A. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. vol 40: 40-50; 2014.
59 Fielding, C. A., McLoughlin, R. M., McLeod, L., Colmont, C. S., Najdovska, M., Grail, D., Ernst, M., Jones, S. A., Topley, N. and Jenkins, B. J. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. Journal of immunology (Baltimore, Md. : 1950). vol 181: 2189-2195; 2008.
60 Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N. and Jones, S. A. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. vol 14: 705-714; 2001.
61 McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A. and Topley, N. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. The Journal of Clinical Investigation. vol 112: 598-607; 2003.
62 Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S. and Poli, G. Interleukin-6 induce monocyte chemotactic protein-1 in perioheral blood mononuclear cells and in the U937 cell line. Blood. vol 91: 258-265; 1998
63 Ribeiro, R. A., Flores, C. A., Cunha, F. Q. and Ferreira, S. H. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology. vol 73: 472-477; 1991.
64 Lee, Y. G., Jeong, J. J., Nyenhuis, S., Berdyshev, E., Chung, S., Ranjan, R., Karpurapu, M., Deng, J., Qian, F., Kelly, E. A., Jarjour, N. N., Ackerman, S. J., Natarajan, V., Christman, J. W. and Park, G. Y. Recruited alveolar macrophages, in response to airway epithelial-derived monocyte chemoattractant protein 1/CCl2, regulate airway inflammation and remodeling in allergic asthma. American Journal of Respiratory Cell and Molecular Biology. vol 52: 772-784; 2015.
65 Collington, S. J., Hallgren, J., Pease, J. E., Jones, T. G., Rollins, B. J., Westwick, J., Austen, K. F., Williams, T. J., Gurish, M. F. and Weller, C. L. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. Journal of immunology (Baltimore, Md. : 1950). vol 184: 6114-6123; 2010.
66 Singh, S. R., Sutcliffe, A., Kaur, D., Gupta, S., Desai, D., Saunders, R. and Brightling, C. E. CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration. Allergy. vol 69: 1189-1197; 2014.
67 Wang, A., Wang, Z., Cao, Y., Cheng, S., Chen, H., Bunjhoo, H., Xie, J., Wang, C., Xu, Y. and Xiong, W. CCL2/CCR2-dependent recruitment of Th17 cells but not Tc17 cells to the lung in a murine asthma model. International Archives of Allergy and Immunology. vol 166: 52-62; 2015.
68 Lukacs, N. W., Strieter, R. M., Warmington, K., Lincoln, P., Chensue, S. W. and Kunkel, S. L. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. The Journal of Immunology. vol. 158: 4398-4404; 1997
69 Hunninghake, G. W., Gadek, J. E., Lawley, T. J. and Crystal, R. G. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. The Journal of Clinical Investigation. vol 68: 259-269; 1981.
70 Obayashi, Y., Yamadori, I., Fujita, J., Yoshinouchi, T., Ueda, N. and Takahara, J. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest. vol 112: 1338-1343; 1997.
71 Papiris, S. A., Tomos, I. P., Karakatsani, A., Spathis, A., Korbila, I., Analitis, A., Kolilekas, L., Kagouridis, K., Loukides, S., Karakitsos, P. and Manali, E. D. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. vol 102: 168-172; 2018.
72 Suga, M., Iyonaga, K., Ichiyasu, H., Saita, N., Yamasaki, H. and Ando, M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. European Respiratory Journal. vol 14: 376-82; 1999.
73 Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine, R., 3rd and Toews, G. B. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. Journal of immunology (Baltimore, Md. : 1950). vol 165: 4032-4039; 2000.
74 Kaplan, G., Walsh, G., Guido, L. S., Meyn, P., Burkhardt, R. A., Abalos, R. M., Barker, J., Frindt, P. A., Fajardo, T. T. and Celona, R. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. The Journal Experimental Medicine. vol 175: 1717-1728; 1992.
75 Xing, Z., Ohkawara, Y., Jordana, M., Graham, F. and Gauldie, J. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. The Journal of Clinical Investigation. vol 97: 1102-1110; 1996.
76 Shiomi, A. and Usui, T. Pivotal roles of GM-CSF in autoimmunity and inflammation. Mediators of inflammation. vol 2015: 2015.
77 Scotton, C. J. and Chambers, R. C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest. vol 132: 1311-1321; 2007.
78 Kuhn, C. and McDonald, J. A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. The American Journal of Pathology. vol 138: 1257-1265; 1991.
79 Hopkins, N. and McLoughlin, P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? Journal of Anatomy. vol 201: 335-348; 2002.
80 Roche, W. R., Beasley, R., Williams, J. H. and Holgate, S. T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet (London, England). vol 1: 520-524; 1989.
81 Salazar, L. M. and Herrera, A. M. Fibrotic response of tissue remodeling in COPD. Lung. vol 189: 101-109; 2011.
82 Fernandez, I. E. and Eickelberg, O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proceedings of the American Thoracic Society. vol 9: 111-116; 2012.
83 Mestecky. J and McGhee, J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Advanced in immunology. vol 40: 153-245; 1987
84 Delacroix. D and Vaerman, J. P. Reassessment of levels of secretory IgA in pathological sera using a quantitative radioimmunoassay. Clinical and Experimental Immunology. vol 43: 633-640; 1981.
85 Phalipon, A., Cardona, A., Kraehenbuhl, J. P., Edelman, L., Sansonetti, P. J. and Corthesy, B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity. vol 17: 107-115; 2002.
86 T. J. F. Reterink WEMS, L. A. van. Es and M. R. Daha. Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells. Mediators of inflammation. vol 5: 191-195; 1996.
87 Amara, K., Clay, E., Yeo, L., Ramskold, D., Spengler, J., Sippl, N., Cameron, J. A., Israelsson, L., Titcombe, P. J., Gronwall, C., Sahbudin, I., Filer, A., Raza, K., Malmstrom, V. and Scheel-Toellner, D. B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis. Journal of Autoimmunity. vol 81: 34-43; 2017.
88 Baumann, J., Park, C. G. and Mantis, N. J. Recognition of secretory IgA by DC-SIGN: implications for immune surveillance in the intestine. Immunology Letters. vol 131: 59-66; 2010.
89 Ishinaga, H., Jono, H., Lim, J. H., Komatsu, K., Xu, X., Lee, J., Woo, C. H., Xu, H., Feng, X. H., Chen, L. F., Chen, Y. and Li, J. D. Synergistic induction of nuclear factor-κB by transforming growth factor-β and tumour necrosis factor-α is mediated by protein kinase A-dependent RelA acetylation. Biochemical Journal. vol. 417: 583-591; 2009.
90 Jiang, X., Takahashi, N., Matsui, N., Tetsuka, T. and Okamoto, T. The NF-κB Activation in Lymphotoxin β Receptor Signaling Depends on the Phosphorylation of p65 at Serine 536. The Journal of Biological Chemistry. vol. 278: 919-926; 2003.
91 Tamouza, H., Chemouny, J. M., Raskova Kafkova, L., Berthelot, L., Flamant, M., Demion, M., Mesnard, L., Paubelle, E., Walker, F., Julian, B. A., Tissandie, E., Tiwari, M. K., Camara, N. O., Vrtovsnik, F., Benhamou, M., Novak, J., Monteiro, R. C. and Moura, I. C. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney International. vol 82: 1284-1296; 2012.
論文の公開元へ
